PF Prism CV

Free public records show PF Prism CV in 2 of the markets we cover. It is not a key player in our research.

Public data

Free public data on PF Prism CV

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

US drug approvals

15 approvals with a product on the US market

  • Bosulif NDA217729 · approved 26 Sep 2023
  • Xalkori NDA217581 · approved 7 Sep 2023
  • Xeljanz NDA203214 · approved 6 Nov 2012
  • Bosulif NDA203341 · approved 4 Sep 2012
  • Inlyta NDA202324 · approved 27 Jan 2012

Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.

See them on openFDA (opens in a new tab)

Markets where public records show them

Markets we cover where free public records show PF Prism CV: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Healthcare Topics

The topics of the markets PF Prism CV is in.

All healthcare topics

Search all reports for PF Prism CV All companies